Cytodyn Inc (CYDY)

[gestalt2]

It is interesting how in past conf. calls the "top priority" was to get the stock price up organically, or with a RS and get uplisted and now it is not even discussed by mgmt. If i remember correctly this was before the last raise that was so damaging to thew stock price. I called the IR guy and that was when i was told the cost in time and money to be uplisted was what ended the drive to do so. I understand the desire to save money and that a buyout is not dependent on what exchange the stock is listed but why all of a sudden this change in attitude? my guess is the ability to raise funds depends on liquidity in the stock price allowing the lowering of risk - which is what happened. Mgmt is pushing pro140's development very quickly which is great but i'm wondering if the financial opportunity has become too much in the favor of these small investment firms.